Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study.
Canonico
Marianne
M
Olié
Valérie
V
Carcaillon
Laure
L
Tubert-Bitter
Pascale
P
Scarabin
Pierre-Yves
PY
D000017:ABO Blood-Group System; D000279:Administration, Cutaneous; D000284:Administration, Oral; D000368:Aged; D015992:Body Mass Index; D016022:Case-Control Studies; D004958:Estradiol / Q000008:administration & dosage / Q000009:adverse effects*; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D004966:Estrogens, Conjugated (USP) / Q000008:administration & dosage / Q000009:adverse effects*; D005165:Factor V / Q000235:genetics; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D016015:Logistic Models; D008875:Middle Aged; D016017:Odds Ratio; D017698:Postmenopause; D018570:Risk Assessment; D012307:Risk Factors; D014648:Varicose Veins / Q000150:complications; D054556:Venous Thromboembolism / Q000097:blood / Q000139:chemically induced / Q000209:etiology* / Q000235:genetics
D000017:ABO Blood-Group System; D004966:Estrogens, Conjugated (USP); C095381:factor V Leiden; D004958:Estradiol; D005165:Factor V